Atezolizumab : Atezolizumab for the treatment of colorectal cancer: the latest evidence and clinical potential

YAP-TEAD Inhibitor 1 : TAOK1-mediated regulation of the YAP/TEAD pathway as a potential therapeutic target in heart failure